NCT07159425

Brief Summary

The goal of this observational study is to observe analgetic and anxiolytic effect of gass mixture of oxygen:nitrigen suboxide 50%:50% in pediatric patients sujected to minimal invasive procedures. The main question it aims to answer is: Does gass mixture of oxygen:nitrigen suboxide 50%:50% has effective anxyolitic and analgetic properties for minimal inavsive procedures in pediatric patients?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 12, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

September 8, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2026

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

1.3 years

First QC Date

April 12, 2025

Last Update Submit

March 16, 2026

Conditions

Keywords

painanxietynitrous oxydechildren

Outcome Measures

Primary Outcomes (3)

  • Pain score for children from 1 to 4 years

    Pain assessed using pain scale: 1-4 years using FLAAC (Face, Leg, Activity, Cry and Consolability) pain scale. Pain was categorized as: 0-no pain, 1-3 mild, 4-6 moderate and 7-10 severe

    5 minutes during the minimal invasive procedure

  • Pain score for children from 4 to 9 years.

    Pain assessed using pain scale: 4-9 years using Wong-Baker Faces Pain Rating Scale. Pain was categorized as: 0-no pain, 1-3 mild, 4-6 moderate and 7-10 severe

    5 minutes during the minimal invasive procedure

  • Pain score for children from 9 to 16 years

    Pain assessed using pain scale: from 9-16 years using Numeric Rating Scale (NRS) Pain was categorized as: 0-no pain, 1-3 mild, 4-6 moderate and 7-10 severe.

    5 minutes during the minimal invasive procedure

Secondary Outcomes (5)

  • anxiolytic effect

    5 minutes during the minimal invasive procedure

  • hypotension

    measured 5 minutes after initiating application of gase mixture of oxygen:nitrogen oxide 50%:50%

  • bradycardia

    measured 5 minutes after initiating application of gase mixture of oxygen:nitrogen oxide 50%:50%

  • desaturation

    measured 5 minutes after initiating application of gase mixture of oxygen:nitrogen oxide 50%:50%

  • level of sedation

    Assessment will be made at the beginig of applicati

Study Arms (1)

Peditric patients planned for minimal invasive procedure

Patients who will be sedated using oxygen:nitrogen suboxide 50%:50% gas mixture for minimal invasive procedure

Eligibility Criteria

Age1 Year - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

single tertiray center random-sample cohort of pediatric patients undergoing any in-hospital minor invasive procedure during a continuous 12 months period of recruitment.

You may qualify if:

  • Age 1-16 years 2 Veinpuncture 3 Arterial line placement 4 Nasogastric tube placement 5 Urinary catheter placement 6 Removal of thoracic drain 7 Skin suture

You may not qualify if:

  • Age \<1 year or \> 16 years
  • Pneumothorax
  • Pneumoperitoneum
  • Pneumocephalus
  • Otitis media
  • Obstructive lung disease
  • Upper airway infection
  • Methylenetetrahydrofolate reductase (MTHF) deficiency
  • Vitamin B12 deficiency
  • Megaloblastic anemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for mother and child health care

Belgrade, Serbia

Location

Related Publications (5)

  • Carbajal R, Biran V, Lenclen R, Epaud R, Cimerman P, Thibault P, Annequin D, Gold F, Fauroux B. EMLA cream and nitrous oxide to alleviate pain induced by palivizumab (Synagis) intramuscular injections in infants and young children. Pediatrics. 2008 Jun;121(6):e1591-8. doi: 10.1542/peds.2007-3104. Epub 2008 May 5.

    PMID: 18458035BACKGROUND
  • Ekbom K, Jakobsson J, Marcus C. Nitrous oxide inhalation is a safe and effective way to facilitate procedures in paediatric outpatient departments. Arch Dis Child. 2005 Oct;90(10):1073-6. doi: 10.1136/adc.2004.060319.

    PMID: 16177164BACKGROUND
  • Zier JL, Liu M. Safety of high-concentration nitrous oxide by nasal mask for pediatric procedural sedation: experience with 7802 cases. Pediatr Emerg Care. 2011 Dec;27(12):1107-12. doi: 10.1097/PEC.0b013e31823aff6d.

    PMID: 22134227BACKGROUND
  • Fein D, Avner JR, Khine H. Pattern of pain management during lumbar puncture in children. Pediatr Emerg Care. 2010 May;26(5):357-60. doi: 10.1097/PEC.0b013e3181db2026.

    PMID: 20404782BACKGROUND
  • Milesi C, Pidoux O, Sabatier E, Badr M, Cambonie G, Picaud JC. Nitrous oxide analgesia for intubating preterm neonates: a pilot study. Acta Paediatr. 2006 Sep;95(9):1104-8. doi: 10.1080/08035250600698818.

    PMID: 16938758BACKGROUND

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Ana Mandras, PhD

    Institute for mother and child health care

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 12, 2025

First Posted

September 8, 2025

Study Start

October 3, 2024

Primary Completion

January 3, 2026

Study Completion

January 3, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

In order to protect individual patients data IPD will not br shared

Locations